Picture of Valerio Therapeutics SA logo

ALVIO — Valerio Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Onxeo Implements Equity Line Financing With Nice & Green

June 15 (Reuters) - ONXEO SA  C4X.PA :
    * ONXEO IMPLEMENTS AN EQUITY LINE FINANCING INCLUDING AN
INCENTIVE
PROGRAM WITH NICE & GREEN SA
    * CASH FOR OPERATIONS EXTENDED TO Q3 2020
    * ISSUANCE OF NEW SHARES OVER A 10-MONTH PERIOD REPRESENTING
A
MAXIMUM AMOUNT OF EUR 5.4 MILLION
    * FINANCING EXTENDS COMPANY'S CASH HORIZON TO Q3 2020
    * AMOUNTS RECEIVED WILL BE ALLOCATED TO ONGOING CLINICAL
DEVELOPMENT OF COMPANY'S LEAD PROGRAM, ASIDNA
    * SHARES WILL BE ISSUED BASED ON AVERAGE OF VOLUME WEIGHTED
AVERAGE SHARE PRICE OF 3 TRADING DAYS PRECEDING ISSUANCE

Source text for Eikon:  ID:nBw6qgQPja 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))

Recent news on Valerio Therapeutics SA

See all news